Multicenter RCT to evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm
Multicenter RCT to evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm
批准号:
MR/N006062/1
负责人:
Nusrat Husain
金额:
$109.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Suicide is a serious global public health issue ranked amongst the leading causes of death in many countries. The worldwide rates of suicide have increased by 60% in the last 45 years, and the 1.8% total global burden of disease attributed to suicide in 1998 is expected to increase to 2.4% by 2020. The WHO Mental Health Action Plan 2013-2020 and all the member states have committed to work towards the global target of a 10% reduction in the suicide rate by 2020. WHO's Mental Health Gap Action Programme includes suicide as one of the priority conditions and the recent WHO report "Preventing suicide: a global imperative" calls for suicide prevention to be a high priority on the global public health agenda. More than 800 000 people across the world die due to suicide each year and for each suicide there are more than 20 people attempting suicide. Each suicide takes the life of the individual and has a tremendous effect on friends, family and the wider community. Up to 75% of all suicides occur in in low- and middle-income countries where resources and services are limited for treatment and support for people who need. There is a clear gap in the robust evaluation of culturally appropriate suicide prevention strategies in low and middle income countries. Individuals who have a history of self-harm are at much higher risk of dying by suicide than individuals who do not have such a history. The WHO recommends that offering them appropriate treatment should be a key component of all suicide prevention strategies. There are in excess of 100,000 acts of self-harm carried out in Pakistan annually. The aim of the proposed trial is to evaluate the clinical and cost-effectiveness of a culturally adapted psychological therapy (C-MAP) in patients with a history of self-harm. We carried out a study in Karachi to determine the effectiveness of a 6-8 session CBT-based intervention (C-MAP) in people who had recently self-harmed. The assessments were carried out at baseline, 3 & 6 months. There was a significant reduction from baseline in suicidal ideation, severity of depression and hopelessness in the intervention group compared to the Treatment as Usual (TAU) group at each follow up assessment. The findings from this work have highlighted the applicability of such an intervention to health services in Pakistan for patients who present after a self-harm episode. The proposed research will be conducted in Karachi, Lahore, Rawalpindi, Quetta and Peshawar. Participants will be randomized either to the Intervention (C-MAP) or TAU. The existing culturally adapted intervention (C-MAP) includes an evaluation of the self-harm episode, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking and relapse prevention strategies. The intervention will be delivered in six sessions over 12 weeks. Assessments will be conducted at baseline and at 3 months (end of intervention) 6 months and 12 months after randomisation. The outcome measures will include questionnaires to measure the repetition of self-harm, severity of suicidal ideation; depression; hopelessness; quality of life and coping resources. In addition, qualitative interviews and focus groups will provide rich information regarding the experiences of participants and therapists, which will inform the development of more effective and sensitive services for self-harm management. TAU will be standard routine care delivered by local medical, psychiatric and primary care services according to their clinical judgement. A record will be kept of any treatment received by each participant. This trial will provide detailed clinical and cost-effectiveness analyses for the management of self-harm which will inform future research and national clinical practice guidelines. We have established contacts with the ministry of health and once the trial is completed we will enter discussions to present the results to them and attempt to influence policy change.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Journey of maximizing efforts towards suicide prevention in Pakistan through culturally relevant suicide prevention strategies
通过与文化相关的自杀预防策略,最大限度地努力预防巴基斯坦自杀的历程
DOI:
--
发表时间:
2023
期刊:
影响因子:
--
作者:
[Husain Et Al.,]
通讯作者:
Husain Et Al.,
DOI:
10.1192/bjo.2023.581
发表时间:
2023-11-13
期刊:
BJPSYCH OPEN
影响因子:
5.4
作者:
[Husain, Muhammad Omair, Chaudhry, Nasim, Kiran, Tayyeba, Taylor, Peter, Tofique, Sehrish, Khaliq, Ayesha, Naureen, Amna, Shakoor, Suleman, Bassett, Paul, Zafar, Shehla Naeem, Chaudhry, Imran B., Husain, Nusrat]
通讯作者:
Husain, Nusrat
A culturally adapted manual assisted problem solving intervention (CMAP) for adults with a history of self-harm: A multi-centre randomized controlled trial
针对有自残史的成年人的文化适应手动辅助问题解决干预(CMAP):一项多中心随机对照试验
DOI:
--
发表时间:
2022
期刊:
BMC Medicine
影响因子:
9.3
作者:
[Husain Et Al.,]
通讯作者:
Husain Et Al.,
Relationship between risk perception, cultural beliefs and religious coping during COVID-19 pandemic in South Asian Countries CRD42021246475
南亚国家 COVID-19 大流行期间风险认知、文化信仰和宗教应对之间的关系 CRD42021246475
DOI:
--
发表时间:
2022
期刊:
PROSPERO
影响因子:
--
作者:
[Ayesha Khaliq]
通讯作者:
Ayesha Khaliq
Mental Health Policies in Low and Lower Middle- Income Countries (LLMICs): A Narrative Synthesis
低收入和中低收入国家 (LLMIC) 的心理健康政策:叙述综合
DOI:
--
发表时间:
2022
期刊:
PROSPERO
影响因子:
--
作者:
[Farooq Ahmad]
通讯作者:
Farooq Ahmad
A Youth Culturally adapted Manual Assisted Psychological therapy (Y-CMAP) for adolescent Pakistani patients with a recent history of self-harm.
-
批准号:MR/R022461/1
-
项目类别:Research Grant
-
资助金额:$124.39万
-
财政年份:2019
-
负责人:Nusrat Husain
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于RCT的多模态新生儿溶血诊疗法应用及胆红素脑损伤早期预测模型的建立
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:包盈颖
-
依托单位:
中药创新药物研究-基于临床RCT证据的蚕蛹多肽治疗肿瘤相关肌少症中药新药研究
-
批准号:2025C02171
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘小孙
-
依托单位:
基于网络与传统方式结合的混合队列和嵌套RCT研究模式
-
批准号:82174234
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:闫世艳
-
依托单位:
虎斑乌贼内脏多糖的结构解析及其对胆固醇逆转运(RCT)的作用机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:孙玉林
-
依托单位:
乌药诱导miR-33经PPARα-LXRα途径调节RCT拮抗高脂血症的作用机制研究
-
批准号:LYY21H280001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:叶合
-
依托单位:
基于针刺疗法特点的RCT针刺方案充分性评价方法研究
-
批准号:81973968
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:岗卫娟
-
依托单位:
基于RCT途径构建新型PPARγ/LXRα双靶点调血脂药物的研究
-
批准号:81874286
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:向华
-
依托单位:
基于RCT途径和脾主运化理论探讨HDL亚类抗AS作用机制
-
批准号:81072935
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:梁东辉
-
依托单位:
子宫肌瘤超声消融与手术治疗改善患者生命质量的RCT研究
-
批准号:30901234
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2009
-
负责人:周敏
-
依托单位: